Literature DB >> 2621244

Vertical transmission of human T-cell leukemia virus type I (HTLV-I): detection of proviral DNA in HTLV-I carrier gravida.

F Saji1, Y Tokugawa, S Kamiura, Y Samejima, K Ohashi, C Azuma, O Tanizawa.   

Abstract

The seroprevalence rate of human T-cell leukemia virus type I (HTLV-I) in pregnant women in the Osaka district was determined by enzyme-linked immunosorbent assay and Western blot analysis. Twenty-one (1.0%) of 2192 samples tested were positive for both assays and the seropositive parturients were found to be integrated with HTLV-I proviral DNA in their mononuclear cells by a DNA dot blot hybridization assay using HTLV-I DNA probe or by a selective DNA amplification technique using the polymerase chain reaction (PCR). On the other hand, proviral DNA was not detected in cord blood of the neonates born to the carrier mothers, indicating that transplacental infection of HTLV-I during pregnancy could be excluded. The results support the hypothesis that postpartum infection via breast milk plays a significant role among the possible perinatal transmission routes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2621244     DOI: 10.1007/bf00917106

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  17 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Search for possible routes of vertical and horizontal transmission of adult T-cell leukemia virus.

Authors:  S Nakano; Y Ando; M Ichijo; I Moriyama; S Saito; K Sugamura; Y Hinuma
Journal:  Gan       Date:  1984-12

Review 5.  Endogenous type-C RNA viruses of mammalian cells.

Authors:  S A Aaronson; J R Stephenson
Journal:  Biochim Biophys Acta       Date:  1976-12-23

6.  Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus.

Authors:  V S Kalyanaraman; M G Sarngadharan; P A Bunn; J D Minna; R C Gallo
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

7.  Oral infection of a common marmoset with human T-cell leukemia virus type-I (HTLV-I) by inoculating fresh human milk of HTLV-I carrier mothers.

Authors:  K Kinoshita; K Yamanouchi; S Ikeda; S Momita; T Amagasaki; H Soda; M Ichimaru; R Moriuchi; S Katamine; T Miyamoto
Journal:  Jpn J Cancer Res       Date:  1985-12

8.  Primary infection of Japanese infants with adult T-cell leukaemia-associated retrovirus (ATLV): evidence for viral transmission from mothers to children.

Authors:  S Nakano; Y Ando; K Saito; I Moriyama; M Ichijo; T Toyama; K Sugamura; J Imai; Y Hinuma
Journal:  J Infect       Date:  1986-05       Impact factor: 6.072

9.  Adult T-cell lymphoma-leukaemia in Blacks from the West Indies.

Authors:  D Catovsky; M F Greaves; M Rose; D A Galton; A W Goolden; D R McCluskey; J M White; I Lampert; G Bourikas; R Ireland; A I Brownell; J M Bridges; W A Blattner; R C Gallo
Journal:  Lancet       Date:  1982-03-20       Impact factor: 79.321

10.  Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells.

Authors:  M Seiki; R Eddy; T B Shows; M Yoshida
Journal:  Nature       Date:  1984 Jun 14-20       Impact factor: 49.962

View more
  1 in total

1.  High prevalence of human T-lymphotropic virus (HTLV) infection in pregnant women in southern France.

Authors:  C Vignoli; X De Lamballerie; C Zandotti; R De Chesse; C Tamalet; P De Micco
Journal:  Eur J Epidemiol       Date:  1995-02       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.